Retrospective Cohort Study
Copyright ©The Author(s) 2023.
World J Transplant. Sep 18, 2023; 13(5): 276-289
Published online Sep 18, 2023. doi: 10.5500/wjt.v13.i5.276
Table 3 Patient characteristics distributed per extent and outcome of evaluation of their potential living donors presented as total patients (n = 212) and as a comparison between patients with candidate (n = 74) and patients with non-candidate (n = 138) potential living donors.
Characteristics
Total patients, n = 212
Patients with candidate PLDs, n = 74
Patients with non-candidate PLDs, n = 138
P value
mean ± SD (range)/number (%)
Patients per extent of evaluation of their PLDs1, n = 212
Completed 171 (33.5%)54 (73%)17 (12.3%)< 0.001
Completed 1/incomplete 115 (7.1%)7 (9.5%)8 (5.8%)
Completed 1/incomplete 22 (0.9%)2 (2.7%)0 (0%)
Completed 1/not evaluated 17 (3.3%)6 (8.1%)1 (0.7%)
Completed 23 (1.4%)3 (4.1%)0 (0%)
Completed 2/incomplete 11 (0.5%)0 (0%)1 (0.7%)
Completed 32 (0.9%)2 (2.7%)0 (0%)
Incomplete 194 (44.3%)0 (0%)94 (68.1%)
Incomplete 1/not evaluated 11 (0.5%)0 (0%)1 (0.7%)
Incomplete 1/not evaluated 21 (0.5%)0 (0%)1 (0.7%)
Incomplete 213 (6.1%)0 (0%)13 (9.4%)
Incomplete 32 (0.9%)0 (0%)2 (1.5%)
Patients per acceptance of their PLDs1, n = 212
Accepted 144 (20.6%)44 (59.5%)0 (0%)< 0.001
Accepted 1/excluded 18 (3.8%)8 (10.8%)0 (0%)
Accepted 1/excluded 22 (0.9%)2 (2.7%)0 (0%)
Accepted 1/not evaluated 14 (1.9%)4 (5.4%)0 (0%)
Excluded 181 (38.2%)0 (0%)81 (0%)
Excluded 214 (6.6%)0 (0%)14 (10.1%)
Excluded 32 (0.9%)0 (0%)2 (1.5%)
Excluded 1/released 15 (2.4%)1 (1.4%)4 (2.9%)
Excluded 1/regressed 13 (1.4%)1 (1.4%)2 (1.5%)
Excluded 1/not evaluated 12 (0.9%)0 (0%)2 (1.5%)
Excluded 1/not evaluated 21 (0.5%)0 (0%)1 (0.7%)
Excluded 2/released 12 (0.9%)1 (1.4%)1 (0.7%)
Excluded 2/regressed 11 (0.5%)1 (1.4%)0 (0%)
Released 128 (13.2%)7 (9.5%)21 (15.2%)
Released 1/not evaluated 12 (0.9%)2 (2.7%)0 (0%)
Regressed 112 (5.7%)3 (4.1%)9 (6.5%)
Regressed 21 (0.5%)0 (0%)1 (0.7%)